HN001® has an unprecedented claim approved by ANVISA to reduce the risk of eczema
SAO PAULO, June 5, 2023 /PRNewswire/ -- IFF today announced its HOWARU® probiotic strain Lacticaseibacillus rhamnosus HN001® has won the NIS Golden Açaí Awards' Applied Ingredients category. The award, presented at a ceremony in São Paulo, is given in recognition of IFF's HOWARU® HN001® strain contribution to reducing the risk of eczema. The inaugural award ceremony was held alongside the Nutri Ingredients Summit (NIS), an exhibition and conference that focuses on functional ingredients from May 30-31.
In Brazil, IFF has the most strains approved by the Brazilian Health Authorities. HN001® is the only probiotic with an approved health claim for reducing the risk of eczema (atopic dermatitis) in children, pregnant women and babies.
"The award reaffirms our commitment to the development of ingredients that can make a difference in people's quality of life, with proven benefits through scientific studies," said Thais Cruz, sales director, Health, IFF. "This achievement is possible due to the consistency of the results obtained in a long-term follow-up study¹, the innovative delivery technology and a unique product that meets market needs."
In the IFF long-term follow-up study, HN001® was studied with pregnant women, whom consumed the probiotic, and followed up with their babies until they reached 11 years of age, proving the persistence of the benefit even after cessation of probiotic consumption at two years of age.
The theme of this year's award is "The ingredient as a fundamental factor for innovation in the industry". Sponsored by Mintel, companies were awarded in five categories ─ functional and healthy foods, functional and healthy drinks, food supplement, applied ingredients, and sustainable and innovative packaging.
The recognition came for the application of this ingredient in Nouve DA, a food supplement with probiotic powder sold by Mantecorp, and the first launch in the country with the HN001® strain. Other HOWARU® strains approved in Brazil are Bifidobacterium lactis HN019®, Lactobacillus acidophilus NCFM®, Lacticaseibacillus rhamnosus GG and the combination of Bifidobacterium animalis ssp. lactis Bi-07®, Lactobacillus acidophilus NCFM®, Bifidobacterium lactis Bl-04® and Lacticaseibacillus paracasei Lpc-37®. To find out more information about HOWARU® probiotics, visit here.
[1] Wickens et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018 Dec;29(8):808-814. doi: 10.1111/pai.12982. Epub 2018 Nov 14. PMID: 30430649.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter , Facebook, Instagram, and LinkedIn.
©2023 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.
Media Contact:
Amanda Borges
Marketing Communications Manager
+55 11 94503 7604
amanda.borges@iff.com
SOURCE IFF
